In a disclosure to the Shenzhen Stock Exchange, Aier said Temasek Fullerton Alpha, an investment company under Temasek Holdings, and Hillhouse Capital have acquired a total of 61.9 million shares in the company worth about 1.9 billion yuan ($267.88 million).
The company’s controlling shareholder, Aier Medical Investment Group, sold 40.4 million shares, accounting for 1.3 per cent of the company’s total share capital, while shareholder Chen Bang sold 21.5 million shares.
Proceeds from the share sale will be used to acquire properties for Aier to build hospitals. The capital will also be used to accelerate the establishment of professional eye health insurance companies, according to the disclosure.
The acquisition comes less than a week after Aier Eye International (Singapore), a direct wholly owned subsidiary of the Chinese eyecare hospital network, offered to purchase 35 per cent of Singapore-listed ISEC Healthcare Ltd for S$67.1 million ($48.3 million).
ISEC Healthcare provides specialist medical eye care services with ambulatory surgical centres in Malaysia and Singapore.
Aier is a company incorporated in China and listed on the Shenzhen Stock Exchange. It operates a global chain of eyecare medical service institutions, which provide ophthalmic medical services as well as optometry services.